Wellington Biomedical Innovation Master Investors (Cayman) I

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Wellington Biomedical Innovation Master Investors (Cayman) I
CIK #0001903360, 0001787092
EDGAR Form CIK 2011 - 2025
3 [0001787092]
4 [0001787092]
D [0001787092]
SC 13G [0001787092]
3 [0001903360]
4 [0001903360]
SC 13G [0001903360]
Form 13D/13G Filer Form 13D/13G Subject Filed
Wellington Biomedical Innovation Master Investors Cayman II LP MBX Biosciences Inc [2024-09-20]
Wellington Biomedical Innovation Master Investors Cayman I LP Verve Therapeutics Inc [2021-06-28]
Wellington Biomedical Innovation Master Investors Cayman I LP Aligos Therapeutics Inc [2020-10-22]
Form 3/4/5 Subject 2011 - 2025
Metsera, Inc.
Wellington Biomedical Innovation Master Investors (Cayman) I
Upstream Bio, Inc.
Wellington Biomedical Innovation Master Investors (Cayman) I
Zenas BioPharma, Inc.
MBX Biosciences, Inc.
Artiva Biotherapeutics, Inc.
Boundless Bio, Inc.
CARGO Therapeutics, Inc.
RayzeBio, Inc.
Acrivon Therapeutics, Inc.
Nuvalent, Inc.
Verve Therapeutics, Inc.
Edgewise Therapeutics, Inc.
Olema Pharmaceuticals, Inc.
Aligos Therapeutics, Inc.
PMV Pharmaceuticals, Inc.
Dyne Therapeutics, Inc.
Kymera Therapeutics, Inc.
Nurix Therapeutics, Inc.
Forma Therapeutics Holdings, Inc.
Generation Bio Co.
Black Diamond Therapeutics, Inc.
Terms | Privacy | Guide
tony@aum13f.com